SEC Filing Summary: ChromaDex Corporation (8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by ChromaDex Corporation on August 15, 2019. The filing details the closing of a private equity financing and the conversion of outstanding convertible notes. The company is incorporated in Delaware and trades on the Nasdaq Capital Market under the symbol CDXC.
Key Financial Metrics and Capital Structure
- Equity Financing: The company raised $7.0 million through the sale of 1,567,748 shares of Common Stock at a price of $4.465 per share.
- Debt Conversion: Convertible promissory notes with an aggregate principal amount of $10.0 million matured and automatically converted into 2,267,254 shares of Common Stock at the same conversion price of $4.465 per share.
- Total Shares Issued: A combined total of 3,835,002 shares were issued in connection with these events (1,567,748 new shares + 2,267,254 conversion shares).
- Liquidity and Margins: The filing text does not provide specific values for revenue, profit, operating cash flow, or margins.
Material Changes and Agreements
The primary material change is the increase in outstanding share count and the elimination of $10.0 million in debt principal through conversion. In connection with the equity financing, the company entered into a Registration Rights Agreement. This agreement obligates the company to file registration statements for the resale of the new shares. Failure to meet filing or effectiveness deadlines may result in liquidated damages of 1.0% of the aggregate purchase price per month, capped at 5.0%.
Outlook, Risks, and Contingencies
The filing does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard disclosure of the Registration Rights Agreement obligations. The shares issued in both the financing and the note conversion were sold pursuant to exemptions from registration under the Securities Act of 1933 (Section 4(a)(2)/Rule 506 and Section 3(a)(9), respectively).
Investor Verification Checklist
- Verify the updated total share count and diluted earnings per share impact following the issuance of 3,835,002 new shares.
- Confirm the company's current cash position post-closing to assess runway given the lack of revenue data in this filing.
- Review the attached Registration Rights Agreement (Exhibit 99.1) for specific timelines regarding the filing of the resale registration statement.
- Monitor for potential dilution if the company fails to meet the registration deadlines, triggering liquidated damages.